Shi M - Search Results

1

NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.

Wang Y, Tan PY, Handoko YA, Sekar K, Shi M, Xie C, Jiang XD, Dong QZ, Goh BKP, Ooi LL, Gao Z, Hui KM. Wang Y, et al. Among authors: shi m. Int J Cancer. 2019 Aug 1;145(3):662-670. doi: 10.1002/ijc.32134. Epub 2019 Feb 4. Int J Cancer. 2019. PMID: 30653265

2

Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.

Wang Y, Gao B, Tan PY, Handoko YA, Sekar K, Deivasigamani A, Seshachalam VP, OuYang HY, Shi M, Xie C, Goh BKP, Ooi LL, Man Hui K. Wang Y, et al. Among authors: shi m. FASEB J. 2019 Aug;33(8):8759-8770. doi: 10.1096/fj.201802213RR. Epub 2019 Apr 25. FASEB J. 2019. PMID: 31022357 Free PMC article.

A., Sekar, K., Deivasigamani, A., Seshachalam, V. P., OuYang, H.-Y., Shi, M., Xie, C., Goh, B. K. P., Ooi, L. L., Hui, K. M. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth....

A., Sekar, K., Deivasigamani, A., Seshachalam, V. P., OuYang, H.-Y., Shi, M., Xie, C., Goh, B. K. P., Ooi, L. L., Hui, K. M …

3

Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.

Xia H, Chen J, Sekar K, Shi M, Xie T, Hui KM. Xia H, et al. Among authors: shi m. Metabolomics. 2019 Nov 26;15(12):156. doi: 10.1007/s11306-019-1619-x. Metabolomics. 2019. PMID: 31773292

4

Hypoxia-induced modulation of glucose transporter expression impacts ¹⁸F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma.

Xia H, Chen J, Gao H, Kong SN, Deivasigamani A, Shi M, Xie T, Hui KM. Xia H, et al. Among authors: shi m. Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):787-797. doi: 10.1007/s00259-019-04638-4. Epub 2019 Dec 12. Eur J Nucl Med Mol Imaging. 2020. PMID: 31832727

5

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma.

Le Y, Kan A, Li QJ, He MK, Chen HL, Shi M. Le Y, et al. Among authors: shi m. Cancer Cell Int. 2019 Sep 5;19:228. doi: 10.1186/s12935-019-0949-0. eCollection 2019. Cancer Cell Int. 2019. PMID: 31516385 Free PMC article.

6

PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.

Shi F, Shi M, Zeng Z, Qi RZ, Liu ZW, Zhang JY, Yang YP, Tien P, Wang FS. Shi F, et al. Among authors: shi m. Int J Cancer. 2011 Feb 15;128(4):887-96. doi: 10.1002/ijc.25397. Int J Cancer. 2011. PMID: 20473887

7

Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma.

Le Y, Shen JX, Zhang YF, He MK, Kan A, Chen HL, Yu ZS, Li QJ, Shi M. Le Y, et al. Among authors: shi m. J Cancer. 2019 Jan 1;10(3):665-671. doi: 10.7150/jca.28528. eCollection 2019. J Cancer. 2019. PMID: 30719164 Free PMC article.

8

Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.

Lu LH, Zhang YF, Mu-Yan C, Kan A, Zhong XP, Mei J, Ling YH, Li SH, Shi M, Wei W, Guo RP. Lu LH, et al. Among authors: shi m. Dig Liver Dis. 2019 Oct;51(10):1430-1437. doi: 10.1016/j.dld.2019.04.006. Epub 2019 May 1. Dig Liver Dis. 2019. PMID: 31054962 Free article.

9

Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy.

Mei J, Lin WP, Shi F, Wei W, Liang JB, Shi M, Zheng L, Li SH, Guo RP. Mei J, et al. Among authors: shi m, shi f. Eur J Radiol. 2021 Sep;142:109890. doi: 10.1016/j.ejrad.2021.109890. Epub 2021 Aug 4. Eur J Radiol. 2021. PMID: 34375811 Free article.

10

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial.

Meng F, Zhao J, Tan AT, Hu W, Wang SY, Jin J, Wu J, Li Y, Shi L, Fu JL, Yu S, Shen Y, Liu L, Luan J, Shi M, Xie Y, Zhou CB, Wong RW, Lu-En W, Koh S, Bertoletti A, Wang T, Zhang JY, Wang FS. Meng F, et al. Among authors: shi m, shi l. Hepatol Int. 2021 Dec;15(6):1402-1412. doi: 10.1007/s12072-021-10250-2. Epub 2021 Nov 30. Hepatol Int. 2021. PMID: 34850325 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,117 results

Search Page

Filters